Female Pattern Alopecia Clinical Trial
Official title:
An Evaluation of the Effect of the Erchonia ML Scanner (MLS) on the Treatment of Androgenic Alopecia in Females
The purpose of this clinical study is to determine if the Erchonia® ML Scanner (MLS) low level laser light device can help to regrow hair on the scalp of females experiencing hair loss or thinning.
Over 20 million women in the United States suffer from hair loss, and about 40% of those
women are under forty years of age. The emotional aspects of hair loss for females include
anxiety and depression, frustration and poor self-esteem. Androgenetic alopecia is a common
cause of female balding and the most likely reason for excessive hair loss.
It is believed that light therapy of the scalp will provide an effective means to reduce
hair loss and/or stimulate hair growth in females with androgenetic alopecia. Results of
previous studies on low level laser therapy (LLLT) have demonstrated a variety of in vitro
and in vivo effects including increased blood flow, accelerated wound healing, enhanced
production of cytokines and other cellular mediators, increased cellular proliferation,
among a panoply of other effects. Enhanced hair growth has been observed adjacent to treated
areas in various animal models investigating the effects of LLLT. Uncontrolled studies in
humans and spa-based therapies in Europe appear to show that the periodic application of low
intensity light therapy reduces hair loss and appears to increase hair growth. The majority
of these applications utilize light in the red and near-infrared portions of the spectrum.
The Erchonia MLS low level laser is being evaluated for its potential to improve the quality
and quantity of hair on the female scalp. This may improve the quality of life as a result
of improved self-image and may potentially delay or reduce the need for surgical procedures
such as hair transplantation. A successful local therapy would mitigate or reduce the need
for systemic agents such as minoxidil and finasteride, thereby minimizing the potential side
effects of these therapies.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01655108 -
Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
|
Phase 3 | |
| Recruiting |
NCT01662089 -
The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
|
Phase 1/Phase 2 | |
| Completed |
NCT05450861 -
Effect of the Composition From Fish on Promoting Hair Growth
|
N/A |